Molecular formula: | C56H38O31 |
Average mass: | 1206.889 |
Monoisotopic mass: | 1206.139704 |
ChemSpider ID: | 10258694 |
7 of 7 defined stereocentres
(1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3 .1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~34,39~]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34,36,38-pentadecaen-4,17,22,40,44-penton
[German]
[ACD/IUPAC Name](1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3 .1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~34,39~]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34,36,38-pentadecaene-4,17,22,40,44-pentone
[ACD/IUPAC Name](1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-Dihydroxyphényl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromén-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadécahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3 .1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~34,39~]hexatétraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34,36,38-pentadécaène-4,17,22,40,44-pentone
[French]
[ACD/IUPAC Name](1R,2R,20R,42S,46S)-46-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-pentadecahydroxy-3,18,21,41,43-pentaoxanonacyclo[27.13.3.1~38,42~.0~2,20~.0~5,10~.0~11,16~.0~23,28~.0~33,45~.0~34,39~]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34,36,38-pentadecaene-4,17,22,40,44-pentone (non-preferred name)
108906-66-7
[RN]Acutissimin A